Cargando…

Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study

INTRODUCTION: Studies have shown that fetal progenitor cells persist in maternal blood or bone marrow for more than 30 years after delivery. Increased trafficking of fetal cells occurs during pregnancy complications, such as hypertension, preeclampsia, miscarriage and intra-uterine growth restrictio...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wyk, Linda, van der Marel, Jacolien, Schuerwegh, Annemie JM, Schouffoer, Anne A, Voskuyl, Alexandre E, Huizinga, Tom WJ, Bianchi, Diana W, Scherjon, Sicco A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334631/
https://www.ncbi.nlm.nih.gov/pubmed/22053948
http://dx.doi.org/10.1186/ar3510
_version_ 1782230656163512320
author van Wyk, Linda
van der Marel, Jacolien
Schuerwegh, Annemie JM
Schouffoer, Anne A
Voskuyl, Alexandre E
Huizinga, Tom WJ
Bianchi, Diana W
Scherjon, Sicco A
author_facet van Wyk, Linda
van der Marel, Jacolien
Schuerwegh, Annemie JM
Schouffoer, Anne A
Voskuyl, Alexandre E
Huizinga, Tom WJ
Bianchi, Diana W
Scherjon, Sicco A
author_sort van Wyk, Linda
collection PubMed
description INTRODUCTION: Studies have shown that fetal progenitor cells persist in maternal blood or bone marrow for more than 30 years after delivery. Increased trafficking of fetal cells occurs during pregnancy complications, such as hypertension, preeclampsia, miscarriage and intra-uterine growth restriction (IUGR). Women with these pregnancy complications are significantly more often HLA-class II compatible with their spouses. Women who later develop scleroderma also give birth to an HLA-class II child more often. From these prior studies we hypothesized that preeclampsia and other pregnancy complications could be associated with increased levels of fetal cell trafficking, and later be involved in the development of scleroderma. METHODS: This study was a retrospective multi-centre matched case-control study. One-hundred-and-three women with systemic sclerosis (SSc) and 103 women with no history of SSc or other autoimmune disease were given a questionnaire regarding complications during pregnancy, such as hypertension, intra-uterine growth restriction (IUGR) and miscarriage. Conditional logistic regression analysis was used to assess associations. RESULTS: We found a statistically significantly increased incidence of having had a pregnancy history of hypertension or a fetus with IUGR in women who subsequently developed SSc compared to healthy controls. We found an odds ratio of 2.6 (95% confidence interval (CI): 1.1 to 4.6) for hypertensive complications during pregnancy and an odds ratio of 3.9 (95% CI: 1.2 to 12.3) for intra-uterine growth restriction for women with SSc compared to healthy controls. CONCLUSIONS: This is the first study to show an association between hypertensive complications during pregnancy or IUGR and the development of SSc at a later age. We speculate that the pregnancy abnormalities may have resulted in increased fetomaternal trafficking, which may have played a role in the increased incidence of SSc. Further studies are indicated to examine this putative relationship.
format Online
Article
Text
id pubmed-3334631
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33346312012-04-25 Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study van Wyk, Linda van der Marel, Jacolien Schuerwegh, Annemie JM Schouffoer, Anne A Voskuyl, Alexandre E Huizinga, Tom WJ Bianchi, Diana W Scherjon, Sicco A Arthritis Res Ther Research Article INTRODUCTION: Studies have shown that fetal progenitor cells persist in maternal blood or bone marrow for more than 30 years after delivery. Increased trafficking of fetal cells occurs during pregnancy complications, such as hypertension, preeclampsia, miscarriage and intra-uterine growth restriction (IUGR). Women with these pregnancy complications are significantly more often HLA-class II compatible with their spouses. Women who later develop scleroderma also give birth to an HLA-class II child more often. From these prior studies we hypothesized that preeclampsia and other pregnancy complications could be associated with increased levels of fetal cell trafficking, and later be involved in the development of scleroderma. METHODS: This study was a retrospective multi-centre matched case-control study. One-hundred-and-three women with systemic sclerosis (SSc) and 103 women with no history of SSc or other autoimmune disease were given a questionnaire regarding complications during pregnancy, such as hypertension, intra-uterine growth restriction (IUGR) and miscarriage. Conditional logistic regression analysis was used to assess associations. RESULTS: We found a statistically significantly increased incidence of having had a pregnancy history of hypertension or a fetus with IUGR in women who subsequently developed SSc compared to healthy controls. We found an odds ratio of 2.6 (95% confidence interval (CI): 1.1 to 4.6) for hypertensive complications during pregnancy and an odds ratio of 3.9 (95% CI: 1.2 to 12.3) for intra-uterine growth restriction for women with SSc compared to healthy controls. CONCLUSIONS: This is the first study to show an association between hypertensive complications during pregnancy or IUGR and the development of SSc at a later age. We speculate that the pregnancy abnormalities may have resulted in increased fetomaternal trafficking, which may have played a role in the increased incidence of SSc. Further studies are indicated to examine this putative relationship. BioMed Central 2011 2011-11-04 /pmc/articles/PMC3334631/ /pubmed/22053948 http://dx.doi.org/10.1186/ar3510 Text en Copyright ©2011 van Wyk et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
van Wyk, Linda
van der Marel, Jacolien
Schuerwegh, Annemie JM
Schouffoer, Anne A
Voskuyl, Alexandre E
Huizinga, Tom WJ
Bianchi, Diana W
Scherjon, Sicco A
Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
title Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
title_full Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
title_fullStr Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
title_full_unstemmed Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
title_short Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
title_sort increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334631/
https://www.ncbi.nlm.nih.gov/pubmed/22053948
http://dx.doi.org/10.1186/ar3510
work_keys_str_mv AT vanwyklinda increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT vandermareljacolien increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT schuerweghannemiejm increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT schouffoerannea increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT voskuylalexandree increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT huizingatomwj increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT bianchidianaw increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy
AT scherjonsiccoa increasedincidenceofpregnancycomplicationsinwomenwholaterdevelopsclerodermaacasecontrolstudy